| |
 |
|
Class Information
Number: 514/532
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Ester doai > Z-c(=o)-o-y wherein z is hydrogen or an organic radical bonded to the c(=o) by a carbon and y is an organic radical bonded to the oxygen by a carbon > Z-c(=o)-o-y, wherein z contains a benzene ring
Description: Subject matter wherein Z is or contains a benzene ring.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7615574 |
Synergistic composition for treating leukemia |
Nov. 10, 2009 |
| 7572829 |
Pharmaceutical compositions useful in prevention and treatment of Beta-amyloid protein-induced disease |
Aug. 11, 2009 |
| 7537777 |
Synergistic and residual pesticidal compositions containing plant essential oils |
May. 26, 2009 |
| 7531189 |
Synergistic and residual pesticidal compositions containing plant essential oils |
May. 12, 2009 |
| 7495029 |
Prodrugs of (2R)-2-propyloctanoic acid for the treatment of stroke |
Feb. 24, 2009 |
| 7485320 |
Liposome for incorporating large amounts of hydrophobic substances |
Feb. 3, 2009 |
| 7417059 |
Substituted aromatic-ring compounds, process for producing the same and use |
Aug. 26, 2008 |
| 7407985 |
Compounds that abrogate DNA damage induced cell cycle G2 checkpoint and/or augment anti-cancer activity of DNA-damaging treatments |
Aug. 5, 2008 |
| 7407648 |
Merocyanine derivatives for cosmetic use |
Aug. 5, 2008 |
| 7368478 |
Methods for inhibiting angiogenesis and tumor growth |
May. 6, 2008 |
| 7361686 |
Compounds for the treatment of metabolic disorders |
Apr. 22, 2008 |
| 7320966 |
Synergistic and residual pesticidal compositions containing plant essential oils |
Jan. 22, 2008 |
| 7314888 |
Compounds and medicinal use thereof |
Jan. 1, 2008 |
| 7307102 |
Method of preventing or treating estrogen-dependent diseases and disorders |
Dec. 11, 2007 |
| 7288271 |
Chlorogenic acid and an analog thereof for immune system stimulation |
Oct. 30, 2007 |
| 7282520 |
External preparation |
Oct. 16, 2007 |
| 7256215 |
Crystals of 5-hydroxycarbamimidoyl-2-hydroxybenzenesulfonamide derivative |
Aug. 14, 2007 |
| 7244763 |
Compounds that modulate PPAR activity and methods of preparation |
Jul. 17, 2007 |
| 7238680 |
Topical compositions for veterinary uses |
Jul. 3, 2007 |
| 7230003 |
Aromatic prodrugs of propofol, compositions and uses thereof |
Jun. 12, 2007 |
| 7226946 |
Substituted phenol compounds useful for anesthesia and sedation |
Jun. 5, 2007 |
| 7208520 |
Crystals of hydroxynorephedrine derivative |
Apr. 24, 2007 |
| 7192981 |
3,4-dihydroxyhydrocinnamic acid derivative |
Mar. 20, 2007 |
| 7163956 |
Substituted fullerene compositions and their use as antioxidants |
Jan. 16, 2007 |
| 7157458 |
Bifunctional energy-reversible acyl-compositions |
Jan. 2, 2007 |
| 7157078 |
Devices and methods for eliminating termite colonies |
Jan. 2, 2007 |
| 7115660 |
Methods for inhibiting angiogenesis and tumor growth |
Oct. 3, 2006 |
| 7101910 |
Compounds for the treatment of metabolic disorders |
Sep. 5, 2006 |
| 7091243 |
Anti-irritants |
Aug. 15, 2006 |
| 7074826 |
R-NSAID esters and their use |
Jul. 11, 2006 |
| 7064124 |
NF-.kappa.B inhibitor containing substituted benzoic acid derivative as active ingredient |
Jun. 20, 2006 |
| 7060301 |
In situ mono-or diester dicarboxylate compositions |
Jun. 13, 2006 |
| 7053071 |
Induction of apoptosis in cancer cells |
May. 30, 2006 |
| 7037914 |
Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient |
May. 2, 2006 |
| 6992095 |
Stilbene compounds comprising an adamantyl group, compositions and methods thereof |
Jan. 31, 2006 |
| 6984389 |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality |
Jan. 10, 2006 |
| 6972294 |
Compounds, their preparation and use |
Dec. 6, 2005 |
| 6964982 |
Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
Nov. 15, 2005 |
| 6951885 |
Pharmaceutical composition |
Oct. 4, 2005 |
| 6951844 |
Phenyl naphthol ligands for thyroid hormone receptor |
Oct. 4, 2005 |
| 6946485 |
Treatment of post-angioplasty restenosis and atherosclerosis with Ras antagonists |
Sep. 20, 2005 |
| 6943196 |
NF-.kappa.B inhibitor comprising phenylmethyl benzoquinone as the active ingredient |
Sep. 13, 2005 |
| 6936636 |
5-[phenyl-tetrahydronaphthalene-2-yl dihydronaphthalen-2-yl and heteroaryl-cyclopropyl]-pentadienoic acid derivatives having serum glucose reducing activity |
Aug. 30, 2005 |
| 6936266 |
Desquamation/epidermal renewal of the skin and/or combating skin aging |
Aug. 30, 2005 |
| 6930129 |
Methods and devices for providing prolonged drug therapy |
Aug. 16, 2005 |
| 6926902 |
Insecticide transpiration apparatus |
Aug. 9, 2005 |
| 6921777 |
Heteroethynylenic compounds and pharmaceutical and cosmetic compositions containing them |
Jul. 26, 2005 |
| 6919373 |
Methods and devices for providing prolonged drug therapy |
Jul. 19, 2005 |
| 6916848 |
Compounds for the treatment of metabolic disorders |
Jul. 12, 2005 |
| 6894076 |
Esters derived from (RR,SS)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl |
May. 17, 2005 |
|
|
|
